Mar 5, 2026 04:15PM

Mar 3, 2026 06:01AM

Dec 31, 2025 04:14PM

Dec 16, 2025 07:01AM

Nov 17, 2025 07:00AM

Nov 10, 2025 04:19PM

Oct 27, 2025 07:02AM Tonix presents fibromyalgia drug data at rheumatology conference

Oct 17, 2025 07:01AM

Oct 14, 2025 07:03AM

Sep 30, 2025 08:35AM

Sep 18, 2025 08:01AM

Sep 17, 2025 07:01AM

Aug 15, 2025 04:24PM

Aug 15, 2025 01:06PM Tonix Pharma (TNXP) halted, news pending

Aug 15, 2025 07:14AM

Aug 11, 2025 04:17PM

Jul 10, 2025 07:02AM

Jul 9, 2025 04:01PM

Jul 7, 2025 07:03AM

Jul 2, 2025 07:01AM

Jun 12, 2025 06:04AM Tonix Pharma (TNXP) Files $500M Mixed Shelf

May 21, 2025 07:00AM

May 12, 2025 04:37PM

Apr 24, 2025 07:56AM

Apr 9, 2025 07:02AM

Apr 1, 2025 07:01AM

Mar 31, 2025 07:00AM

Mar 29, 2025 08:30AM New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Mar 25, 2025 10:01AM

Mar 24, 2025 08:04AM

Mar 20, 2025 07:00AM

Mar 18, 2025 04:58PM

Mar 12, 2025 07:30AM

Feb 7, 2025 08:33AM

Feb 6, 2025 08:00AM Tonix Pharma (TNXP) Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoim

Feb 4, 2025 07:02AM

Feb 3, 2025 08:05AM

Dec 23, 2024 08:01AM

Dec 17, 2024 08:02AM

Dec 9, 2024 07:30AM

Nov 14, 2024 07:30AM

Nov 13, 2024 09:05AM Tonix Pharma (TNXP) Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised A

Nov 12, 2024 08:11AM

Nov 1, 2024 07:01AM

Oct 17, 2024 08:03AM

Oct 16, 2024 08:05AM

Oct 8, 2024 08:30AM

Oct 1, 2024 07:30AM

Sep 27, 2024 07:00AM Tonix Pharma (TNXP) Issued US Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch to Treat Migraines

Sep 23, 2024 07:07AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All